genome
Industry Trailblazers to Headline this Month’s CRISPR Summit
December 01 by Pharmaceuticals & Biotechnology Editor[inlinead]CRISPR has attracted media attention this year charting potential patent disputes where fortunes could be at stake. Three key heavyweights said to be at the centre of these IP discussions ar...
Epigenetics Market to climb to $16.3bn
October 30 by Chanice HenryA new research report from Grand View Research inc, charts that the international epigenetics market is due to reach US$16.31 billion by 2022. The forecasted growth being fuelled by the increasing f...
Why Not Sequence the Whole Genome?
September 13 by Andrea CharlesProfessor René Bernards, Head of the Division/Group Leader, Molecular Carcinogenesis at The Netherlands Cancer Institute, joins Andrea Charles from Pharma IQ, to discuss current trends in next-ge...
Do You Know Enough About Next-Generation DNA Sequencing in Cancer?
January 20 by Helen WinsorElia Stupka, Scientific Director of Bioinformatics at UCL Genomics, joins Helen Winsor form Pharma IQ, to discuss next-generation DNA sequencing and recent developments in next-generation sequencing t...
Using Next-Generation DNA Sequencing Methods
August 08 by Pharma IQAlthough more than a thousand bacterial genomes have been sequenced, our understanding of bacterial transcriptomes has lagged far behind. Transcript structure, operon linkages, and absolute mRNA ...